Abstract

BackgroundDrug repositioning is the process of identifying new targets for known drugs. It can be used to overcome problems associated with traditional drug discovery by adapting existing drugs to treat new discovered diseases. Thus, it may reduce associated risk, cost and time required to identify and verify new drugs. Nowadays, drug repositioning has received more attention from industry and academia. To tackle this problem, researchers have applied many different computational methods and have used various features of drugs and diseases.ResultsIn this study, we contribute to the ongoing research efforts by combining multiple features, namely chemical structures, protein interactions and side-effects to predict new indications of target drugs. To achieve our target, we realize drug repositioning as a recommendation process and this leads to a new perspective in tackling the problem. The utilized recommendation method is based on Pareto dominance and collaborative filtering. It can also integrate multiple data-sources and multiple features. For the computation part, we applied several settings and we compared their performance. Evaluation results show that the proposed method can achieve more concentrated predictions with high precision, where nearly half of the predictions are true.ConclusionsCompared to other state of the art methods described in the literature, the proposed method is better at making right predictions by having higher precision. The reported results demonstrate the applicability and effectiveness of recommendation methods for drug repositioning.

Highlights

  • Drug repositioning is the process of identifying new targets for known drugs

  • Realizing the fact that this approach is similar to collaborative filtering in the recommendation systems domain, we adapted for drug repositioning a method that we previously proposed for classical recommendation purposes [29]

  • When we look at Item Selection Type (IST), we observe that using weighted sum (WSUM) performs better than using sum (SUM)

Read more

Summary

Introduction

It can be used to overcome problems associated with traditional drug discovery by adapting existing drugs to treat new discovered diseases It may reduce associated risk, cost and time required to identify and verify new drugs. A recent study, published in 2014 [7], revealed that developing a new medicine and getting its market approval takes more than 10 years and costs more than $2.5 billion In response to these costs, drug repositioning has recently received considerable attention as a good alternative which could reduce both time and cost associated with seeking new drugs for emerging diseases.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call